Arlanov, Rudolf; Porter, Andrew; Strand, Dennis et al.
Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cellsHUMAN MUTATION. Bd. 33. H. 4. 2012 S. 750-762
Igawa, Y; Schneider, T; Yamazaki, Y et al.
Functional investigation of beta-adrenoceptors in human isolated detrusor focusing on the novel selective beta 3-adrenoceptor agonist KUC-7322NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 385. H. 8. 2012 S. 759-767
Karbach, S; Jansen, T; Horke, S et al.
Hyperglycemia and oxidative stress in cultured endothelial cells - a comparison of primary endothelial cells with an immortalized endothelial cell lineJOURNAL OF DIABETES AND ITS COMPLICATIONS. Bd. 26. H. 3. 2012 S. 155-162
Graf, J.; Benedikt, S.; Habermeier, A. et al.
Identification of the amino acid transporter, responsible for Fluoroethyltyrosine (FET) uptake in glioblastomaNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 385. 2012 S. 30-30
Art, J; Besche, V; Bros, M et al.
Identification of the KH type splicing regulatory protein (KSRP) as a new important mediator of the anti-inflammatory effects of resveratrolNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 385. 2012 S. 6-6
Closs, EI; Ostad, MA; Simon, A et al.
Impairment of the extrusion transporter for asymmetric dimethyl-L-arginine: A novel mechanism underlying vasospastic anginaBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. Bd. 423. H. 2. 2012 S. 218-223
Roggli, E.; Gattesco, S.; Pautz, A. et al.
Involvement of the RNA-binding protein ARE/poly(U)-binding factor 1 (AUF1) in the cytotoxic effects of proinflammatory cytokines on pancreatic beta cellsDIABETOLOGIA. Bd. 55. H. 6. 2012 S. 1699-1708
Bollmann, F; Wu, Z; Oelze, M et al.
Is a Chronic Inflammation the Main Trigger for Cardiovascular Diseases?NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 385. 2012 S. 13-14
Dubois, M; Delannoy, E; Duluc, L et al.
Lack of evidence for a role of BH4/BH2-dependent eNOS uncoupling in hypoxia-induced pulmonary hypertensionFUNDAMENTAL & CLINICAL PHARMACOLOGY. Bd. 26. 2012 S. 19-19
Blot, K; Michel, MC
Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs ResponseBRITISH JOURNAL OF CLINICAL PHARMACOLOGY. Bd. 74. H. 1. 2012 S. 209-210